The Presynaptic α2δ Protein Family and Their Therapeutic Potential
Recent publication
The book "Ion Channels as Targets in Drug Discovery", published by Springer-Verlag, deals with drug research on various ion channels. Success stories and innovative research approaches are presented. In the chapter "The Presynaptic α2δ Protein Family and Their Therapeutic Potential", the Division of Physiology explains the role of the α2δ protein family in various diseases such as epilepsy, pain and restless legs syndrome. A better understanding of the role of the α2δ protein family in neurological disorders supports the development of new therapeutic approaches.
Ablinger, C, Eibl, C, Roznovcova, M, Cottrell, GS, Stephens, GJ & Obermair, GJ 2024, The Presynaptic α2δ Protein Family and Their Therapeutic Potential. in G Stephens & E Stevens (eds), Ion Channels as Targets in Drug Discovery., Chapter 3, Springer International Publishing AG, pp. 57-89. https://doi.org/10.1007/978-3-031-52197-3_3
Cornelia Ablinger, MSc.
Wiss. Mitarbeiterin (PhD) im Rahmen des CavX PhD Programms an der Medizinischen Universität Innsbruck
Division of Physiology
Dr. Clarissa Eibl MA
Scientific Staff (Sen. PostDoc)
Division of Physiology
Univ.-Prof. Mag. Dr. Gerald Obermair
Head of
Division of Physiology
